Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group
- 31 January 1998
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 68 (1) , 45-46
- https://doi.org/10.1006/gyno.1997.4887
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A gynecologic oncology group studyCancer, 1994
- Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.Proceedings of the National Academy of Sciences, 1991
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986